Low dose aspirin should not be used for primary prevention in older people as it has no benefit and increases the risk of major bleeding events, an Australian RCT has shown. The Aspirin in Reducing Events in the Elderly (ASPREE) trial compared the effects of 100mg daily aspirin and placebo in more than 19,000 healthy people ...
Bleeding risk with low dose aspirin outweighs benefit in primary prevention
By Michael Woodhead
18 Sep 2018